Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
艾克替尼作为EGFR突变II-IIIA期肺腺癌患者的辅助治疗(ICWIP研究):一项随机对照试验的研究方案
期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S240275
Liu, Yu-Tao; Hao, Xue-Zhi; Liu, De-Ruo; Cheng, Gang; Zhang, Shu-Cai; Xiao, Wen-Hua; Hu, Yi; Liu, Jun-Feng; He, Ming; Ding, Cui-Min; Zhang, Li; Wang, Jun; Li, Hui; Dong, Gui-Lan; Zhi, Xiu-Yi; Li, Jian; Shi, Yuan-Kai